A detailed history of Capital Investment Counsel, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Investment Counsel, Inc holds 5,425 shares of EW stock, worth $367,598. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,425
Previous 5,425 -0.0%
Holding current value
$367,598
Previous $501,000 28.74%
% of portfolio
0.05%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$84.3 - $94.31 $77,556 - $86,765
-920 Reduced 14.5%
5,425 $501,000
Q1 2024

May 01, 2024

BUY
$72.54 - $95.56 $7,254 - $9,556
100 Added 1.6%
6,345 $606,000
Q4 2023

Feb 05, 2024

SELL
$61.71 - $77.76 $6,171 - $7,776
-100 Reduced 1.58%
6,245 $476,000
Q3 2023

Nov 02, 2023

SELL
$69.28 - $93.38 $47,110 - $63,498
-680 Reduced 9.68%
6,345 $439,000
Q1 2023

Apr 27, 2023

SELL
$74.26 - $84.51 $29,704 - $33,804
-400 Reduced 5.39%
7,025 $581,000
Q4 2022

Jan 31, 2023

BUY
$68.3 - $87.44 $335,011 - $428,893
4,905 Added 194.64%
7,425 $553,000
Q3 2022

Oct 26, 2022

BUY
$82.37 - $107.29 $3,294 - $4,291
40 Added 1.61%
2,520 $208,000
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $263,797 - $324,086
2,480 New
2,480 $321,000
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $255,216 - $304,420
-2,480 Closed
0 $0
Q2 2021

Jul 27, 2021

BUY
$83.84 - $104.76 $6,707 - $8,380
80 Added 3.33%
2,480 $257,000
Q1 2021

May 05, 2021

SELL
$78.68 - $90.67 $94,416 - $108,804
-1,200 Reduced 33.33%
2,400 $201,000
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $138,096 - $184,680
2,400 Added 200.0%
3,600 $249,000
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $11,792 - $18,225
-225 Reduced 15.79%
1,200 $226,000
Q4 2019

Jan 29, 2020

SELL
$71.7 - $82.09 $7,170 - $8,209
-100 Reduced 6.56%
1,425 $332,000
Q3 2018

Oct 31, 2018

BUY
$45.7 - $58.03 $3,427 - $4,352
75 Added 5.17%
1,525 $266,000
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $61,552 - $74,385
1,450 New
1,450 $211,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Investment Counsel, Inc Portfolio

Follow Capital Investment Counsel, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, Inc with notifications on news.